LINEAGE THERAPLINEAGE THERAPLINEAGE THERAP

LINEAGE THERAP

No trades
See on Supercharts

LCTX fundamentals

An in-depth look to LINEAGE THERAP operating, investing, and financing activities

LCTX free cash flow for Q2 24 is -19.75 M ILS. For 2023, LCTX free cash flow was -106.17 M ILS and operating cash flow was -103.72 M ILS.

Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: ILS
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Free cash flowYoY growth